Lupus & antiphospholipid syndrome

Trends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of America

LupusPublished Retrospective cohort study

Authors' conclusion

PKT trends increased from 1985 to 2019 in patients with lupus, PKD and GD. PKT patients with lupus have lower risk of KAF and mortality compared to patients with DM.

Study context

Population
Incident End-stage Kidney Disease (ESKD) patients in the United States Renal Data System (USRDS)3,001,746 non-lupus
Exposure
Lupus vs non-lupus primary diseases leading to ESKD
  • Lupusn = 33,415
Outcome
Trends of preemptive kidney transplantation (PKT)
Methodological detailsregistry-based (USRDS), Cochran-Armitage trend tests, adjusted Cox models
  • Registry-based (USRDS)
  • Cochran-Armitage trend tests
  • Adjusted Cox models

Main finding

As reported in the abstract

PKT trends

Lupus

3.02% to 4.65%

Polycystic kidney disease (PKD)

3.14% to 16.71%

Glomerular diseases (GD)

3.94% to 5.90%

DM

2.11% to 0.71%

Hypertension (HTN)

1.15% to 0.92%

Other diseases (OD)

3.89% to 3.60%

Increase in Lupus
P = 0.001
Increase in PKD
P < 0.001
Increase in GD
P < 0.001
Decrease in DM
P < 0.001
Decrease in HTN
P < 0.001
Decrease in OD
P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeValuesHR (95% CI)
Kidney allograft failure (KAF) in PKT recipients, rate per 100 patient-yearsLupusvs DMAdjusted Cox modelsLupus 4.40 per 100 patient-years · PKD 2.47 per 100 patient-years · GD 4.28 per 100 patient-years · OD 4.84 per 100 patient-years · DM 6.24 per 100 patient-years · HTN 7.42 per 100 patient-years0.85 (0.76–0.95)
All-cause mortality in PKT recipients, rateLupusvs DMAdjusted modelsLupus 2.59 · PKD 2.20 · GD 2.62 · OD 2.99 · HTN 6.39 · DM 6.490.56 (0.50–0.64)

Original publication

Trends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of America. Lupus. Published 20 May 2025. doi:10.1177/09612033251344189

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.